Literature DB >> 23354234

Chasing 100%: the use of hypertonic saline to improve early, primary fascial closure after damage control laparotomy.

John A Harvin1, Mark M Mims, Juan C Duchesne, Charles S Cox, Charles E Wade, John B Holcomb, Bryan A Cotton.   

Abstract

BACKGROUND: Failure to achieve fascial closure after damage control laparotomy (DCL) is associated with increased morbidity and long-term disability. In addition, early closure is associated with reduces infectious, wound, and pulmonary complications. We hypothesized that hypertonic saline (HTS), which attenuates resuscitation-induced intestinal edema in animals, would improve early primary fascial closure (EPFC) rates.
METHODS: This is a retrospective study of trauma patients undergoing DCL, from January 2010 to July 2011. Patients in the HTS group had 30 mL/h of 3% sodium chloride as maintenance fluids while the fascia was open. Patients in the cohort group had isotonic fluids (125 mL/h). The primary outcome, EPFC, was defined as primary fascial closure by postinjury day 7.
RESULTS: Seventy-seven patients underwent DCL (23 received HTS and 54 received isotonic fluids). There were no differences in demographics, injury severity, or pre-intensive care unit vitals, laboratories, fluids, or transfusions. Median fluids in the first 24 hours were lower in the HTS group (3.9 vs. 7.8 L, p < 0.001). Times to fascial closure were shorter in those receiving HTS (34 vs. 49 hours, p < 0.001), as were the rates of closure at first take back (78% vs. 53%, p = 0.036). The primary outcome of EPFC was higher in the HTS group compared with standard fluids (100% vs. 76%, p = 0.010). At discharge, the HTS group had a 96% primary fascial closure rate compared with 80% with standard fluids.
CONCLUSION: The use of 3% HTS as maintenance fluids after DCL was associated with 100% EPFC. HTS may be used as an adjunct to facilitate fascial closure in patients undergoing DCL. LEVEL OF EVIDENCE: Diagnostic study, level III.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23354234     DOI: 10.1097/TA.0b013e31827e2a96

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  10 in total

1.  The impact of standardized protocol implementation for surgical damage control and temporary abdominal closure after emergent laparotomy.

Authors:  Tyler J Loftus; Philip A Efron; Trina M Bala; Martin D Rosenthal; Chasen A Croft; Michael S Walters; R Stephen Smith; Frederick A Moore; Alicia M Mohr; Scott C Brakenridge
Journal:  J Trauma Acute Care Surg       Date:  2019-04       Impact factor: 3.313

2.  Hypertonic saline resuscitation after emergent laparotomy and temporary abdominal closure.

Authors:  Tyler J Loftus; Philip A Efron; Trina M Bala; Martin D Rosenthal; Chasen A Croft; R Stephen Smith; Frederick A Moore; Alicia M Mohr; Scott C Brakenridge
Journal:  J Trauma Acute Care Surg       Date:  2018-02       Impact factor: 3.313

3.  Temporary abdominal closure for trauma and intra-abdominal sepsis: Different patients, different outcomes.

Authors:  Tyler J Loftus; Janeen R Jordan; Chasen A Croft; R Stephen Smith; Philip A Efron; Alicia M Mohr; Frederick A Moore; Scott C Brakenridge
Journal:  J Trauma Acute Care Surg       Date:  2017-02       Impact factor: 3.313

4.  Planned re-laparotomy and the need for optimization of physiology and immunology.

Authors:  L Kobayashi; R Coimbra
Journal:  Eur J Trauma Emerg Surg       Date:  2014-03-27       Impact factor: 3.693

Review 5.  The open abdomen in trauma and non-trauma patients: WSES guidelines.

Authors:  Federico Coccolini; Derek Roberts; Luca Ansaloni; Rao Ivatury; Emiliano Gamberini; Yoram Kluger; Ernest E Moore; Raul Coimbra; Andrew W Kirkpatrick; Bruno M Pereira; Giulia Montori; Marco Ceresoli; Fikri M Abu-Zidan; Massimo Sartelli; George Velmahos; Gustavo Pereira Fraga; Ari Leppaniemi; Matti Tolonen; Joseph Galante; Tarek Razek; Ron Maier; Miklosh Bala; Boris Sakakushev; Vladimir Khokha; Manu Malbrain; Vanni Agnoletti; Andrew Peitzman; Zaza Demetrashvili; Michael Sugrue; Salomone Di Saverio; Ingo Martzi; Kjetil Soreide; Walter Biffl; Paula Ferrada; Neil Parry; Philippe Montravers; Rita Maria Melotti; Francesco Salvetti; Tino M Valetti; Thomas Scalea; Osvaldo Chiara; Stefania Cimbanassi; Jeffry L Kashuk; Martha Larrea; Juan Alberto Martinez Hernandez; Heng-Fu Lin; Mircea Chirica; Catherine Arvieux; Camilla Bing; Tal Horer; Belinda De Simone; Peter Masiakos; Viktor Reva; Nicola DeAngelis; Kaoru Kike; Zsolt J Balogh; Paola Fugazzola; Matteo Tomasoni; Rifat Latifi; Noel Naidoo; Dieter Weber; Lauri Handolin; Kenji Inaba; Andreas Hecker; Yuan Kuo-Ching; Carlos A Ordoñez; Sandro Rizoli; Carlos Augusto Gomes; Marc De Moya; Imtiaz Wani; Alain Chichom Mefire; Ken Boffard; Lena Napolitano; Fausto Catena
Journal:  World J Emerg Surg       Date:  2018-02-02       Impact factor: 5.469

6.  What's new in critical illness and injury science? Management of the open abdomen: Getting it together!

Authors:  Prerna Ladha; Michael Callander; Ziad C Sifri
Journal:  Int J Crit Illn Inj Sci       Date:  2019 Apr-Jun

Review 7.  Open Abdomen in a Critically Ill Patient.

Authors:  Lalita Gouri Mitra; Vandana Saluja; Udit Dhingra
Journal:  Indian J Crit Care Med       Date:  2020-09

8.  Bioelectrical impedance analysis-guided fluid management promotes primary fascial closure after open abdomen: a randomized controlled trial.

Authors:  Wei-Wei Ding; Jie-Shou Li; Kai Wang; Shi-Long Sun; Xin-Yu Wang; Cheng-Nan Chu; Ze-Hua Duan; Chao Yang; Bao-Chen Liu; Wei-Qin Li
Journal:  Mil Med Res       Date:  2021-06-07

9.  Abdominal damage control surgery and reconstruction: world society of emergency surgery position paper.

Authors:  Laura Godat; Leslie Kobayashi; Todd Costantini; Raul Coimbra
Journal:  World J Emerg Surg       Date:  2013-12-17       Impact factor: 5.469

Review 10.  Open abdomen critical care management principles: resuscitation, fluid balance, nutrition, and ventilator management.

Authors:  Elizabeth Chabot; Ram Nirula
Journal:  Trauma Surg Acute Care Open       Date:  2017-09-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.